Close Menu
    Wissenschaft

    Eine randomisierte, placebokontrollierte Doppelblind-Pilotstudie mit einer oralen Einzeldosis Ivermectin zur Postexpositionsprophylaxe von SARS-CoV-2

    Share.
    View 7 Comments

    7 Kommentare

    1. rjkardo on

      “Conclusions: We did not demonstrate that a single oral low dose of Ivermectin administered to asymptomatic adults within 72 h of close contact with a case of SARS-CoV-2 prevents conversion to a positive PCR or RAT. “

      Still a very small sample size study with a minimal impact.

    2. TunaNugget on

      My understanding was that the corticosteroids that were used to treat Covid cases at the beginning of the pandemic could make parasitic infections much worse. So the association of Ivermectin with better Covid outcomes depended on the prevalence of these parasites at the particular location of the individual studies.

      Edit:

      [Comparison of Trials Using Ivermectin for COVID-19 Between Regions With High and Low Prevalence of StrongyloidiasisA Meta-analysis](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2790173)

      – JAMA Network Open

    3. JaySayMayday on

      The people that could benefit the most from this study typically don’t reach much.

    5. Loopy13 on

      I know people got made fun of for thinking there was a case of Ivermectin use but I’m glad studies can get done like this to officially put the issue to bed rather than just call the people silly or stupid.

    6. translinguistic on

      Taking *anything* published in MDPI as gospel is a terrible idea. It’s one of the lowest bars to getting published and has a really bad reputation.

    Leave A Reply